The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Lumicell is specializing in the field of image-guided cancer surgery. The company's technology illuminates cancer cells in the tumor cavity, enabling physicians to take action in real-time to improve patient outcomes. The company's lead product, consisting of a fluorescent optical contrast agent and a handheld illumination device, is currently under clinical investigation in patients undergoing breast cancer surgery. A planned pivotal study aims to evaluate the ability of the technology to reduce positive margin rates and reduce repeat surgeries while sparing healthy tissue. Lumicell technology is also being investigated in colorectal cancer, Barrett’s Esophagus, pancreatic cancer, and brain metastases. In clinical studies to date, no cancer has been missed and the safety profile of the optical contrast agent has been demonstrated. Lumicell was founded in 2008 and is based in Newton, MA, USA.

Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity. (Contact Tamir Huberman) Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.

Onyvax is developing new cancer therapies that harness the selective power of the immune system to seek out and destroy tumor cells. Onyvax's products specifically target cancer cells, increasing the likelihood that they will be effective while minimising side effects associated with many conventional treatments. These therapies can broadly be classed as therapeutic cancer vaccines.

CEA is a French government-funded technological research organisation. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world. The CEA is the French Alternative Energies and Atomic Energy Commission (Commissariat à l'énergie atomique et aux énergies alternatives). It is a public body established in October 1945 by General de Gaulle. A leader in research, development and innovation, the CEA mission statement has two main objectives: To become the leading technological research organization in Europe and to ensure that the nuclear deterrent remains effective in the future. The CEA is active in four main areas: low-carbon energies, defense and security, information technologies and health technologies. In each of these fields, the CEA maintains a cross-disciplinary culture of engineers and researchers, building on the synergies between fundamental and technological research. The total CEA workforce consisted of 15 838 employees. Across the whole of the CEA (including both civilian and military research), there were 1556 PhD students and 293 post-docs. The CEA is based in ten research centers in France, each specializing in specific fields. The laboratories are located in the Paris region, the Rhône-Alpes, the Rhône valley, the Provence-Alpes-Côte d'Azur region, Aquitaine, Central France and Burgundy. The CEA benefits from the strong regional identities of these laboratories and the partnerships forged with other research centers, local authorities and universities.

Alxa League Yuehe Technology Ecology Co., Ltd., established on 1999-06-25, Business scope includes licensed business items:Wholesale and retail:Pre-packaged food,dairy products(Does not contain infant formula)limited to branch operations.General operating items:Science and Technology Ecological Economic Development,Research on Practical Technology of Agriculture, Forestry and Trees,Seedling production and sales,Agricultural technology extension application and service;Agriculture, Forestry and Grass Planting,Livestock and poultry farming,aquaculture;farming,Forest,livestock,Aquatic product processing and sales(Operate with animal quarantine certificate);Chinese herbal medicine planting and processing,Crop straw processing,Psammophyte planting and processing;Deep processing of agricultural and sideline products,Dumplings,Sales,frozen,refrigeration,Warehouse rental.(National laws and regulations stipulate that those that should be subject to examination and approval shall not be produced and operated without approval)

SMT Bio Co., Ltd. is a company headquartered in Seoul, the South Korea, specializing in commercial physical and biological research. It was founded in 2015. Yong-Yoon Jung is currently the CEO of the firm.

Zhenyue Biotechnology Jiangsu Co., Ltd., established on 2015-12-16, Business scope includes biotechnology development,Technical Services,technology transfer,technical consulting,software development,data processing(without foundation,added value,Telecommunications business),Sales of computer software, hardware and auxiliary equipment,Chemical Products(Free of Hazardous Chemicals),Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export),R&D of medical devices,production and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Yunnan Ruifen Biotechnology Co., Ltd., established on 2015-08-17, Business scope includes biotechnology research,to develop,Technical consulting and technology transfer;Processing and sales of agricultural and sideline products;Enterprise management and information consulting;Goods and technology import and export business(Except for products and technologies that are restricted or prohibited by the state)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Wuxi Zhenhe Biotechnology Co., Ltd., established on 2014-11-17, Business scope includes licensed projects:Import and export agency(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software development;Data processing and storage support services;Medical Research and Experimental Development;Retailing of computer software, hardware and auxiliary equipment;Communication equipment wholesale;Retailing of Class I Medical Devices;Wholesale of Class I Medical Devices;Wholesale of chemical products(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Yanying Biotechnology (Suzhou) Co., Ltd., established on 2020-10-15, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Internet Information Service for Medical Devices;Drug retail(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Domestic trade agent;software development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Network technology service;Information Technology Consulting Services;Medical Research and Experimental Development;Manufacturing of experimental analysis instruments;Manufacturing of special equipment(Manufacture of licensed professional equipment not included)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

Florigene Mooncarnation is a supplier of potted plants, bedding plants, vegetable plants, cut flowers, and accessories.

Chengdu West China Precision Medicine Industry Technology Research Institute Co., Ltd., established on 2017-05-27, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Health Consulting Services(Does not include medical services);Intellectual Property Services(Except for patent agency services);Technology intermediary service;Science popularization service;3Dprint service;business management;Corporate Headquarters Management;Production of Class I Medical Devices;Sales of Class I Medical Devices;Class I Medical Device Leasing;Sales of Class II Medical Devices;Class II Medical Device Leasing(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Class III Medical Device Leasing;Drug Clinical Trial Services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Guangdong Sifeng Biotechnology Co., Ltd., established on 2016-07-20, Business scope includes medical research and experimental development;Engineering and Technology Research and Experimental Development;R&D and application of cell technology;Biochemical product technology research and development;Natural science research and experimental development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Cosmetics Wholesale;Cosmetics Retail;Manufacturing of daily chemical products;Sales of daily chemical products;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of hygiene products and single-use medical products;Fermentation process optimization technology research and development;Human stem cell technology development and application;Development of Human Gene Diagnosis and Therapy Technology;Cosmetic production;food production;food sales;food business;Health food production;Health food sales;Production of hygiene products and single-use medical products;pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug retail;

Shenzhen Yingji Biotechnology Development Co., Ltd., established on 2012-12-12, Business scope includes general business items:Technical development of biological products.,The licensing program is: